New! Learn more about the all new DeepDyve personalized home page where you can quickly skim your favorite journals all from one place
Urologic Oncology: Seminars and Original Investigations
-
2012
-
Volume 30
-
-
2011
-
2010
-
2009
-
2008
-
2007
-
2006
-
2005
-
2004
-
2003
-
2002
-
2001
-
2000
-
1998
-
1997
-
1996
-
1995
-
Bookmark
More Like This 8sumR0oymV $3.99
Commentary on “Health-related quality of life after single-fraction high-dose-rate brachytherapy and hypofractionated external beam radiotherapy for prostate cancer.” Morton GC, Loblaw DA, Chung H, Tsang G, Sankreacha R, Deabreu A, Zhang L, Mamedov A, Cheung P, Batchelar D, Danjoux C, Szumacher E, Department of Radiation Oncology, Odette Cancer Centre, University of Toronto, Toronto, ON, Canada
Gottschalk, Alexander
Follow Urologic Oncology: Seminars and Original Investigations , Volume 30 (3)
Elsevier – May 1, 2012 -
Bookmark
More Like This gJ0QRSNozN $3.99
-
Bookmark
More Like This id0U8cNwm4 $3.99
High matrix metalloproteinase-to-E-cadherin ratio measured by bicolor fluorescent in situ hybridization is associated with lymphangiogenesis and lymph node metastasis in prostate cancer
Luo, Yi; Ohmori, Hitoshi; Fujii, Kiyomu; Chihara, Yoshitomo; Maruyama, Satoshi; Kuniyasu, Hiroki
Follow Urologic Oncology: Seminars and Original Investigations , Volume 30 (3)
Elsevier – May 1, 2012 -
Bookmark
More Like This HNXxs5VPXM $3.99
Commentary on “Multi-institutional phase II study of proton beam therapy for organ-confined prostate cancer focusing on the incidence of late rectal toxicities.” K. Nihei, T. Ogino, M. Onozawa, S. Murayama, H. Fuji, M. Murakami, Y. Hishikawa, Radiation Oncology Division, National Cancer Centre, Hospital East, Kashiwa, Japan
Gottschalk, Alexander
Follow Urologic Oncology: Seminars and Original Investigations , Volume 30 (3)
Elsevier – May 1, 2012 -
Bookmark
More Like This c4WYfVx0eL $3.99
Masthead
Follow Urologic Oncology: Seminars and Original Investigations , Volume 30 (3)
Elsevier – May 1, 2012 -
Bookmark
More Like This VmSUGnFP9X $3.99
The incidence and management of metachronous testicular germ cell tumors in patients with extragonadal germ cell tumors
Hashimoto, Kenji; Fujimoto, Hiroyuki; Kouno, Tsutomu; Koseki, Masahiro; Yonemori, Kan; Hirata, Taizo; Yunokawa, Mayu; Shimizu, Chikako; Katsumata, Noriyuki; Tamura, Kenji; Ando, Masashi; Takeuchi, Masahiro; Nakanishi, Hiroyuki; Komiyama, Motokiyo; Nakagawa, Tohru; Fujiwara, Yasuhiro
Follow Urologic Oncology: Seminars and Original Investigations , Volume 30 (3)
Elsevier – May 1, 2012 -
Bookmark
More Like This b3Gmq33uR7 $3.99
Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ confined urothelial carcinoma following radical nephroureterectomy
Wheat, Jeffery C.; Weizer, Alon Z.; Wolf, J. Stuart; Lotan, Yair; Remzi, Mesut; Margulis, Vitaly; Wood, Christopher G.; Montorsi, Francesco; Roscigno, Marco; Kikuchi, Eiji; Zigeuner, Richard; Langner, Cord; Bolenz, Christian; Koppie, Theresa M.; Raman, Jay D.; Fernández, Mario; Karakiewizc, Pierre; Capitanio, Umberto; Bensalah, Karim; Patard, Jean-Jacques; Shariat, Shahrokh F.
Follow Urologic Oncology: Seminars and Original Investigations , Volume 30 (3)
Elsevier – May 1, 2012 -
Bookmark
More Like This M021KwG7EZ $3.99
Endorectal T2-weighted MRI does not differentiate between favorable and adverse pathologic features in men with prostate cancer who would qualify for active surveillance
Guzzo, Thomas J.; Resnick, Matthew J.; Canter, Daniel J.; Bivalacqua, Trinity J.; Rosen, Mark A.; Bergey, Meredith R.; Magerfleisch, Laurie; Tomazewski, John E.; Wein, Alan J.; Malkowicz, S. Bruce
Follow Urologic Oncology: Seminars and Original Investigations , Volume 30 (3)
Elsevier – May 1, 2012 -
Bookmark
More Like This egAoQdHsi8 $3.99
Commentary on “Image-guided dose-escalated intensity-modulated radiation therapy for prostate cancer: Treating to doses beyond 78 Gy.” Eade TN, Guo L, Forde E, Vaux K, Vass J, Hunt P, Kneebone A, Departments of Radiation Oncology, Urology, Royal North Shore Hospital, Sydney, NSW, Australia
Gottschalk, Alexander
Follow Urologic Oncology: Seminars and Original Investigations , Volume 30 (3)
Elsevier – May 1, 2012 -
Bookmark
More Like This bM9Fe34x7w $3.99
Commentary on “Twice-weekly hypofractionated intensity-modulated radiotherapy for localized prostate cancer with low-risk nodal involvement: Toxicity and outcome from a dose escalation pilot study.” T. Zilli, S. Jorcano, M. Rouzaud, G. Dipasquale, P. Nouet, J.I. Toscas, N. Casanova, H. Wang, L. Escudé, M. Mollà, D. Linero, D.C. Weber, R. Miralbell, Service de Radio-oncologie, Hôpitaux Universitaires de Genève, Geneva, Switzerland
Gottschalk, Alexander
Follow Urologic Oncology: Seminars and Original Investigations , Volume 30 (3)
Elsevier – May 1, 2012
© 2012 DeepDyve, Inc. All rights reserved.
Terms of Service | Privacy Policy
